Start Date
Immediate
Expiry Date
17 Dec, 26
Salary
75000.0
Posted On
18 Sep, 26
Experience
15 year(s) or above
Remote Job
Yes
Telecommute
Yes
Sponsor Visa
No
Skills
Industry
Healthcare & Life Sciences
Vertanical – A World Free of Chronic Pain. We are a leading global biopharmaceutical company specializing in the development and distribution of innovative medicines for the treatment of chronic pain. Our vision is clear: a world free of chronic pain! With VER-01, we have developed a unique cannabinoid-based medicine for the treatment of chronic pain, which was approved in Germany and Austria in June 2026 under the name Exilby. This marks a significant milestone after more than eight years of intensive research and development.
Approval in the USA is planned for 2029. Our goal is to establish Exilby as the leading therapy for the treatment of chronic pain by 2030, setting new standards in pain management. Does
this sound exciting to you? Then apply now! We look forward to getting to know you.
Shape the future of pain therapy with us! In this role, you will ensure the highest quality standards in our clinical trials. You will actively contribute to our Clinical Quality Assurance System, identify risks early, and ensure compliance with regulatory requirements. Working closely with internal teams and external partners, you will drive improvements and ensure consistent quality implementation. Ready to take on responsibility and make a real difference? Then we're looking for you!
How To Apply:
Incase you would like to apply to this job directly from the source, please click here
Vertanical – A World Free of Chronic Pain. We are a leading global biopharmaceutical company specializing in the development and distribution of innovative medicines for the treatment of chronic pain. Our vision is clear: a world free of chronic pain! With VER-01, we have developed a unique cannabinoid-based medicine for the treatment of chronic pain, which was approved in Germany and Austria in June 2026 under the name Exilby. This marks a significant milestone after more than eight years of intensive research and development.
Approval in the USA is planned for 2029. Our goal is to establish Exilby as the leading therapy for the treatment of chronic pain by 2030, setting new standards in pain management. Does
this sound exciting to you? Then apply now! We look forward to getting to know you.
Shape the future of pain therapy with us! In this role, you will ensure the highest quality standards in our clinical trials. You will actively contribute to our Clinical Quality Assurance System, identify risks early, and ensure compliance with regulatory requirements. Working closely with internal teams and external partners, you will drive improvements and ensure consistent quality implementation. Ready to take on responsibility and make a real difference? Then we're looking for you!